These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 24395554)
1. Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice. Wilhelm AJ; Rhoads JP; Wade NS; Major AS Ann Rheum Dis; 2015 Apr; 74(4):778-85. PubMed ID: 24395554 [TBL] [Abstract][Full Text] [Related]
2. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice. Braun Na; Wade NS; Wakeland EK; Major AS Lupus; 2008 Dec; 17(12):1070-8. PubMed ID: 19029274 [TBL] [Abstract][Full Text] [Related]
3. Low expressions of PD-L1 and CTLA-4 by induced CD4 Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334 [TBL] [Abstract][Full Text] [Related]
4. CD4 Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848 [TBL] [Abstract][Full Text] [Related]
5. IL-6 alters migration capacity of CD4 He S; Xue M; Cai G Scand J Immunol; 2021 Nov; 94(5):e13099. PubMed ID: 34940981 [TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice. van Leuven SI; Mendez-Fernandez YV; Wilhelm AJ; Wade NS; Gabriel CL; Kastelein JJ; Stroes ES; Tak PP; Major AS Ann Rheum Dis; 2012 Mar; 71(3):408-14. PubMed ID: 21953346 [TBL] [Abstract][Full Text] [Related]
7. Increased CD4 Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752 [TBL] [Abstract][Full Text] [Related]
8. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide. Sharabi A; Lapter S; Mozes E J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183 [TBL] [Abstract][Full Text] [Related]
9. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Stanic AK; Stein CM; Morgan AC; Fazio S; Linton MF; Wakeland EK; Olsen NJ; Major AS Proc Natl Acad Sci U S A; 2006 May; 103(18):7018-23. PubMed ID: 16636270 [TBL] [Abstract][Full Text] [Related]
10. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. Pan X; Yuan X; Zheng Y; Wang W; Shan J; Lin F; Jiang G; Yang YH; Wang D; Xu D; Shen L PLoS One; 2012; 7(4):e34662. PubMed ID: 22506043 [TBL] [Abstract][Full Text] [Related]
11. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]